IP Library Granted Patent US 12,133,934
Granted Patent B2
US 12,133,934 · App. 18/315,502 · Granted Nov 5, 2024

Intravascular devices

Inventors: Hancun Chen (San Ramon, CA); Andrew S. Lee (San Jose, CA); Brent Gerberding (San Jose, CA)
Assignees: Stryker Corporation; Stryker European Holdings, LLC
A61L31/022A61L31/14A61B17/1214A61F2002/016A61F2002/068A61F2/90A61F2/95C22C5/04C22C27/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,133,934
App. No.
18/315,502
Granted
Nov 5, 2024
Kind
B2
Abstract

An implantable medical device includes an elongate member having a cross-sectional dimension that is less than 0.00085 inch, wherein the elongate member is made from a material comprising a platinum-tungsten alloy having a percentage of tungsten that is at least 10% by weight or alternatively the implantable medical device includes an elongate member made from a material comprising an alloy containing rhenium.

Claims (21)

1. An implantable medical device, comprising:

an elongate member made from a material, the material comprising an alloy that includes Platinum (Pt), Tungsten (W), and Zirconium (Zr);

wherein a percentage of the Tungsten (W) in the alloy is equal to or greater than 10% by weight;

wherein a percentage of the Platinum (Pt) and Tungsten (W) in the alloy is at least 95% by weight, and wherein a percentage of the Zirconium (Zr) in the alloy is 5% or less by weight.

2. The implantable medical device of claim 1 , wherein the elongate member has a cross-sectional dimension that is less than 0.002 inch.

3. The implantable medical device of claim 2 , wherein the cross-sectional dimension of the elongate member is anywhere from 0.0001 inch to 0.0008 inch.

4. The implantable medical device of claim 2 , wherein the cross-sectional dimension of the elongate member is anywhere from 0.0003 inch to 0.00075 inch.

5. The implantable medical device of claim 1 , wherein the percentage of Tungsten (W) in the alloy is less than 25% by weight.

6. The implantable medical device of claim 1 , wherein the elongate member has a greater ultimate tensile strength, a greater Young's modulus, and a lesser magnetic susceptibility, than those in identically dimensioned alternative elongate member composed of an alternative platinum-tungsten alloy having a percentage of tungsten that is 8% by weight.

7. The implantable medical device of claim 1 , wherein the material has a Young' modulus of 30 Msi or higher.

8. The implantable medical device of claim 1 , wherein the material has an ultimate tensile strength (UTS) that is 350 ksi or higher.

9. The implantable medical device of claim 1 , wherein the elongate member comprises a wire.

10. The implantable medical device of claim 9 , further comprising additional wires, wherein the wire and the additional wires are woven into a braid structure.

11. The implantable medical device of claim 10 , further comprising a first coil segment at a first end of the braid structure.

12. The implantable medical device of claim 10 , wherein the braid structure has a wire count that is anywhere from 8 to 96.

13. The implantable medical device of claim 9 , wherein the wire has a helical coil shape.

14. The implantable medical device of claim 1 ,

wherein the implantable medical device has a longitudinal axis and a length measured in a direction of the longitudinal axis that is at least 1.2 inch,

wherein the implantable medical device is insertable lengthwise into an inner lumen of a tube having an inner lumen diameter not greater than 0.02 inch, and

wherein the implantable medical device has a column strength sufficient to allow the implantable medical device to be pushed through the lumen without undergoing buckling, kinking, or plastic deformation.

15. The implantable medical device of claim 1 , wherein the alloy comprising the Platinum (Pt), the Tungsten (W), and the Zirconium (Zr) is not a Mo—Re alloy.

Assignments (2)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2023
From: CHEN, HANCUN; LEE, ANDREW S.; GERBERDING, BRENT
To: STRYKER CORPORATION; STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 063612/0880 →